Tag: PARTNER II

TCT 2016: Transfemoral TAVI improves quality of life in intermediate-risk patients

Data presented at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA) indicate that intermediate-risk patients who undergo transcatheter aortic...

What is required for TAVI to become the new gold standard?

Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of aortic stenosis and has entered international guideline recommendations.1,2...

TAVI with Sapien 3 may be better than surgery for intermediate-risk...

A ccording to Vinod H Thourani (Emory University School of Medicine, Atlanta, USA) and others, intermediate-risk patients undergoing transcatheter aortic valve implantation (TAVI) with the...